AEON Biopharma Statistics
Total Valuation
AEON Biopharma has a market cap or net worth of $33.59 million. The enterprise value is $44.84 million.
Important Dates
The next estimated earnings date is Monday, November 11, 2024, before market open.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AEON Biopharma has 39.52 million shares outstanding. The number of shares has decreased by -68.99% in one year.
Current Share Class | 39.52M |
Shares Outstanding | 39.52M |
Shares Change (YoY) | -68.99% |
Shares Change (QoQ) | +4.23% |
Owned by Insiders (%) | 6.13% |
Owned by Institutions (%) | 5.28% |
Float | 17.55M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.39
Current Ratio | 0.39 |
Quick Ratio | 0.33 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -597.69% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$30.55M |
Employee Count | 10 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.84% in the last 52 weeks. The beta is 0.40, so AEON Biopharma's price volatility has been lower than the market average.
Beta (5Y) | 0.40 |
52-Week Price Change | -81.84% |
50-Day Moving Average | 0.93 |
200-Day Moving Average | 4.05 |
Relative Strength Index (RSI) | 38.07 |
Average Volume (20 Days) | 73,573 |
Short Selling Information
The latest short interest is 153,113, so 0.39% of the outstanding shares have been sold short.
Short Interest | 153,113 |
Short Previous Month | 68,653 |
Short % of Shares Out | 0.39% |
Short % of Float | 0.87% |
Short Ratio (days to cover) | 0.74 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -43.96M |
Pretax Income | -323.95M |
Net Income | -305.52M |
EBITDA | -43.86M |
EBIT | -43.96M |
Earnings Per Share (EPS) | -$7.10 |
Full Income Statement Balance Sheet
The company has $3.44 million in cash and $14.69 million in debt, giving a net cash position of -$11.25 million or -$0.28 per share.
Cash & Cash Equivalents | 3.44M |
Total Debt | 14.69M |
Net Cash | -11.25M |
Net Cash Per Share | -$0.28 |
Equity (Book Value) | -27.95M |
Book Value Per Share | -0.71 |
Working Capital | -6.41M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -43.40M |
Capital Expenditures | n/a |
Free Cash Flow | -43.40M |
FCF Per Share | -$1.10 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |